New hope for tough ovarian cancer? early trial launches
Disease control
Not yet recruiting
This early-phase study tests a new drug called WSK-IM02 in 36 women whose ovarian cancer has stopped responding to platinum chemotherapy. The main goal is to check the drug's safety and find the right dose, not to cure the disease. Participants will be closely monitored for side …
Phase: PHASE1 • Sponsor: WestVac Biopharma Co., Ltd. • Aim: Disease control
Last updated May 17, 2026 07:08 UTC